AUPH announcements Aurinia Pharmaceuticals Inc announcements and dividends declared NASDAQ

Aurinia Pharmaceuticals Inc Complete list of announcements declared & dividend announcements by Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals Inc AUPH listed on NASDAQ and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Aurinia Pharmaceuticals Inc AUPH

Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Tops Revenue Estimates
Aurinia Pharmaceuticals (AUPH) came out with a quarterly loss of [CO].09 per share versus the Zacks Consensus Estimate of a loss of [CO].17. This compares to loss of [CO].06 per share a year ago. These figures are adjusted for non-recur
Announcement as on 02 November 2023

Aurinia Pharmaceuticals Share Surge Shows Investor Support for Board Reboot, Strategic Review
Shares of Aurinia Pharmaceuticals (US:AUPH) are up almost 14% in Friday’s premarket activity following a series of director departures and news of a strategic review of potential sale or merger opportunities.Exiting the board of the Edmonton, Alberta
Announcement as on 30 June 2023

Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Aurinia Pharmaceuticals (AUPH) came out with a quarterly loss of [CO].18 per share versus the Zacks Consensus Estimate of a loss of [CO].24. This compares to loss of [CO].27 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 04 May 2023

RSI Alert: Aurinia Pharmaceuticals (AUPH) Now Oversold
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength
Announcement as on 19 August 2022

Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates
Aurinia Pharmaceuticals (AUPH) came out with a quarterly loss of [CO].27 per share versus the Zacks Consensus Estimate of a loss of [CO].26. This compares to loss of [CO].40 per share a year ago. These figures are adjusted for non-recurring items.
Announcement as on 10 May 2022

Announcements by Aurinia Pharmaceuticals Inc first page | Next page |

AUPH Aurinia Pharmaceuticals Inc current price & indicator signals

Moving Averages for Aurinia Pharmaceuticals Inc

  • 5Day Average: 8.61
  • 12Day Average: 8.89
  • 20Day Average: 9.19
  • 50Day Average: 8.37
  • 100Day Average: 7.57
  • 150Day Average: 6.89
  • 200Day Average: 6.46

AUPH Indicators & signals

Indicator MACD (12,26,9)

8.83, 8.8, 0.18
Indicator MACD is in positive zone

Indicator ADX (14)

12.5, 18.92, 24.32
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 62
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of AUPH Aurinia Pharmaceuticals Inc are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
07 Tue Jan 2025 8.42 8.34 to 8.57 0.48% 1.24 times
06 Mon Jan 2025 8.38 8.33 to 8.68 -1.87% 1.46 times
03 Fri Jan 2025 8.54 8.52 to 8.96 -2.62% 1.41 times
02 Thu Jan 2025 8.77 8.76 to 9.10 -2.12% 1.34 times
31 Tue Dec 2024 8.96 8.91 to 9.23 -2.29% 0.9 times
30 Mon Dec 2024 9.17 8.99 to 9.30 -0.33% 0.92 times
27 Fri Dec 2024 9.20 8.99 to 9.26 -0.54% 0.72 times
26 Thu Dec 2024 9.25 8.90 to 9.26 3.01% 0.68 times
24 Tue Dec 2024 8.98 8.89 to 9.01 0.34% 0.43 times
23 Mon Dec 2024 8.95 8.93 to 9.05 -0.89% 0.82 times
20 Fri Dec 2024 9.03 8.92 to 9.23 -0.11% 1.32 times
19 Thu Dec 2024 9.04 8.93 to 9.21 -0.66% 1 times

Videos related to: AUPH announcements Aurinia Pharmaceuticals Inc announcements and dividends declared NASDAQ

Videos related to: AUPH announcements Aurinia Pharmaceuticals Inc announcements and dividends declared NASDAQ

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

AUPH announcements Aurinia Pharmaceuticals Inc announcements and dividends declared NASDAQ

 

Back to top